Tradestie Institutional Equity Comparison Engine

PTCT vs IONS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PTCT Overall Edge

PTCT Captures Institutional Edge (3โ€“1 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to PTC Therapeutics, Inc. (PTCT) driven by superior Valuation, Growth & Margin, Momentum & Technical while IONS counters with relative strength in Options & Structure. Fundamentally, PTCT trades at 19.9x Forward P/E with 21.5% operating margin (+69.6% YoY revenue) versus IONS at 90.9x Forward P/E and -58.8% operating margin (+54.9% YoY). In options structure, PTCT sits in BREAKDOWN (17th %ile IV; Dealer Gamma Walls on Pro) against IONS sits in BREAKDOWN (17th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner PTCT
PTCT 19.9x vs IONS 90.9x Fwd P/E
Growth & Margin Winner PTCT
Op Margin 21.5% vs -58.8% ยท YoY +69.6% vs +54.9%
Momentum & Technical Winner PTCT
1Y -17.8% vs -59.1% ยท 52W Pos 9% vs 2%
Options & Structure Winner IONS
BREAKDOWN (17th %ile IV) vs BREAKDOWN (17th %ile IV)
PTCT NASDAQ
PTC Therapeutics, Inc.
Pharmaceutical Preparations
$61.62
-2.95% 1D
Market Cap $5.3B
1M Return +4.02%
1Y Return -17.79%
Forward P/E 19.9x
Unified AI Score
45.4 / 100 HOLD
Tech 48.0 Fund 54.0 Flow 69.0 Mom 50.0
IONS NASDAQ
Ionis Pharmaceuticals, Inc. Common Stock
Pharmaceutical Preparations
$28.57
-1.7% 1D
Market Cap $4.7B
1M Return -33.48%
1Y Return -59.1%
Forward P/E 90.9x
Unified AI Score
63.9 / 100 BUY
Tech 60.0 Fund 63.0 Flow 73.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PTCT -17.79% IONS -59.1% Spread: +41.31 pp (PTCT Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period PTCT Revenue IONS Revenue PTCT Op. Margin IONS Op. Margin Margin Edge
FY2018 $260M $600M -43.7% -10.2% IONS
FY2019 $310M $1.12B -78.6% 32.6% IONS
FY2020 $380M $730M -113.4% -23.6% IONS
FY2021 $540M $810M -69.5% -3.7% IONS
FY2022 $700M $590M -64.0% -69.8% PTCT
FY2023 $940M $790M -46.9% -44.9% IONS
FY2024 $810M $710M -37.5% -67.4% PTCT
FY2025 $1.73B $940M 50.1% -40.4% PTCT

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PTCT (8) vs IONS (2)
Institutional Metric PTCT IONS Criterion Row Winner
Market Capitalization Scale $5.3B $4.7B Larger Scale PTCT
Trailing P/E Ratio Valuation 19.4x 90.9x Lower Multiple PTCT
Forward P/E Ratio Valuation 19.9x 90.9x Lower Multiple PTCT
Revenue Growth (YoY) Growth +69.6% +54.9% Higher Growth PTCT
Operating Margin (TTM) Profitability 21.5% -58.8% Higher Margin PTCT
Net Profit Margin Profitability -9.2% -56.9% Higher Margin PTCT
Return on Equity (ROE) Capital Efficiency -7740.1% -108.0% Higher ROE IONS
52-Week Range Position Momentum 9% ($59โ€“$91) 2% ($27โ€“$87) Stronger Trend PTCT
Beta / 30D Volatility Risk Regime 0.81ฮฒ ยท 58% Vol 0.18ฮฒ ยท 86% Vol Lower Realized Risk PTCT
Unified Institutional Score Composite Signal 45.4 / 100 (HOLD) 63.9 / 100 (BUY) Higher Composite IONS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PTCT vs IONS Buy Guide
PTCT BREAKDOWN
91d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 17th %ile
IV Regime Compressed (<25th %ile)
Live PTCT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
IONS BREAKDOWN
58d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 17th %ile
IV Regime Compressed (<25th %ile)
Live IONS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PTCT nor IONS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.